Results 41 to 50 of about 2,050,369 (162)

Optimizing the Banking and Releasing Strategies of Clinical-Grade HLA-Homozygous Human iPSCs for Regenerative Medicine

open access: yesStem Cells International
Since their initial generation, induced pluripotent stem cells (iPSCs) have attracted considerable attention and undergone rapid development. iPSC-derived cell therapies show great promise in the field of regenerative medicine.
Qianping Zhang   +12 more
doaj   +1 more source

Low-liver-accumulation lipid nanoparticles enhance the efficacy and safety of HPV therapeutic tumor vaccines

open access: yesJournal of Translational Medicine
Background Lipid nanoparticles (LNPs) hold significant potential in vaccine and cancer therapy, but conventional LNPs often cause hepatotoxicity and reduced efficacy due to liver accumulation.
Xiaodie Wang   +12 more
doaj   +1 more source

Automated image analysis detects aging in clinical-grade mesenchymal stromal cell cultures

open access: yesStem Cell Research & Therapy, 2018
Background Senescent cells are undesirable in cell therapy products due to reduced therapeutic activity and risk of aberrant cellular effects, and methods for assessing senescence are needed. Early-passage mesenchymal stromal cells (MSCs) are known to be
S. Oja   +4 more
doaj   +1 more source

Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review

open access: yesTumor Biology, 2020
Homeobox genes function as master regulatory transcription factors during development, and their expression is often altered in cancer. The HOX gene family was initially studied intensively to understand how the expression of each gene was involved in ...
Danielle Barbosa Brotto   +11 more
doaj   +1 more source

Therapeutic efficacy of thrombin-preconditioned mesenchymal stromal cell-derived extracellular vesicles on Escherichia coli-induced acute lung injury in mice

open access: yesRespiratory Research
Background Acute lung injury (ALI) following pneumonia involves uncontrolled inflammation and tissue injury, leading to high mortality. We previously confirmed the significantly increased cargo content and extracellular vesicle (EV) production in ...
Yuna Bang   +8 more
doaj   +1 more source

Why Extracellular Vesicles Are Attractive Vehicles for RNA-Based Therapies?

open access: yesSynBio
Extracellular Vesicles (EVs) are a focus of intense research worldwide, with many groups exploring their potential for both diagnostic and therapeutic applications. Researchers have characterized EVs into various subtypes, modified common surface markers,
Farah Aqel   +4 more
doaj   +1 more source

Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy

open access: yesJournal of Market Access & Health Policy, 2018
Background: Market access stakeholders consider the adoption of Managed Entry Agreements (MEAs), however a clearly described methodology to quantify their implementation burden is not available in the public domain.
Panos Kefalas   +7 more
doaj   +1 more source

Application of Raman Spectroscopy and Univariate Modelling As a Process Analytical Technology for Cell Therapy Bioprocessing

open access: yesFrontiers in Medicine, 2018
Cell therapies offer unquestionable promises for the treatment, and in some cases even the cure, of complex diseases. As we start to see more of these therapies gaining market authorization, attention is turning to the bioprocesses used for their ...
Marc-Olivier Baradez   +3 more
doaj   +1 more source

Aptamer guided nanomedicines enable precision immune engineering

open access: yesDiscover Applied Sciences
Precision targeting of immune responses is crucial for the ongoing development of therapies for cancer, autoimmune, and infectious diseases. Aptamers, which are short, single-stranded oligonucleotides, are emerging as powerful immunomodulators in ...
Nowar Alsarayreh   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy